-
Mashup Score: 1
Miranda Kleijn, PhD, Agendia, Amsterdam, Netherlands, shares the findings of a comparative assessment of MammaPrint and BluePrint genetic assay results…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Denosumab is a monoclonal antibody targeting RANK ligand (RANKL). Evidence has implicated RANKL in the development of BRCA1-associated breast cancer…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Phase III trial of denosumab for breast cancer risk reduction in BRCA1 carriers w/ Judy Garber of @DanaFarber Watch here 👉https://t.co/WHC3MXzEN8👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc
-
-
Mashup Score: 0
Judy Garber, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, shares the findings of a Phase II randomized study (NCT01196936) of…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Tamoxifen reduces breast cancer risk in chest-irradiated cancer survivors w/ Judy Garber of @DanaFarber Watch here 👉https://t.co/AYGJzm3XPL👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc
-
-
Mashup Score: 0
Miranda Kleijn, PhD, Agendia, Amsterdam, Netherlands, discusses the FLEX study (NCT03053193), a large-scale, prospective, observational trial of patients with stage…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: The FLEX database is expediting genomic discoveries in breast cancer w/ Miranda Kleijn of Agendia Watch here 👉https://t.co/oMrbupUbqT👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc
-
-
Mashup Score: 0St. Gallen Consensus highlights: ovarian suppression, oligometastatic disease and radiotherapy - 3 year(s) ago
Jean-Yves Pierga, MD, PhD, Institut Curie, Paris, France, talks on the major topics discussed at the St. Gallen International Breast…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: St. Gallen Consensus highlights: ovarian suppression, oligometastatic disease and radiotherapy w/ Jean-Yves Pierga of @institut_curie Watch here 👉https://t.co/KR8TX1Lvyl👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BCsm #BreastCancer #OncoAlert #MedOnc
-
-
Mashup Score: 05-year DMFS outcomes in the NBREaST II trial - 3 year(s) ago
Miranda Kleijn, PhD, Agendia, Amsterdam, Netherlands, shares the 5-year follow-up results of the NBREaST II trial, assessing the use of…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: 5-year DMFS outcomes in the NBREaST II trial w/ Miranda Kleijn of Agendia Watch now 👉https://t.co/AWsdKYM3QV👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc
-
-
Mashup Score: 1Genomic testing in early breast cancer: MammaPrint & BluePrint - 3 year(s) ago
Genomic testing in early-stage breast cancer can give useful insights above and beyond the clinical and pathological features. Several gene…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Genomic testing in early breast cancer: MammaPrint & BluePrint w/ Miranda Kleijn of Agendia Watch here 👉https://t.co/7DsX1G5G8u👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc
-
-
Mashup Score: 0Identifying novel predictive biomarkers in breast cancer - 3 year(s) ago
Ashutosh Nerurka, MD, The Royal Marsden NHS Foundation Trust, London, UK, shares his thoughts on major areas of breast cancer…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Identifying novel predictive biomarkers in breast cancer w/ Ashutosh Nerurka of @royalmarsdenNHS Watch the interview here 👉https://t.co/jHI20eJXM9👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc
-
-
Mashup Score: 0Escalation of adjuvant therapy in HR+ breast cancer - 3 year(s) ago
Nicolò Battisti, MD, The Royal Marsden NHS Foundation Trust, London, UK, shares his thoughts on exciting areas of breast cancer…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Escalation of adjuvant therapy in HR+ breast cancer w/ @nicolobattisti of @royalmarsdenNHS Watch the video here 👉https://t.co/eQRa0zGWxh👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc
-
-
Mashup Score: 0
Analysis of cell-free DNA (cfDNA) enables non-invasive sampling of tumor DNA and recent evidence supports its use as a promising…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: The potential of circulating cell-free DNA as a #BreastCancer biomarker w/ Maria Panagopoulou of Democritus University of Thrace Watch here 👉 https://t.co/xx4YfCbElD👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BCsm #OncoAlert #MedOnc #ClinOnc #NCRM21 #ResearchSavesLives
-
VIDEO: Genomic assay performance: core needle biopsy vs. surgical resection samples w/ Miranda Kleijn of Agendia Watch here 👉https://t.co/8oAELi8AzJ👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc